Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrons | 9 | 2025 | 17 | 1.280 |
Why?
|
| Mental Disorders | 5 | 2025 | 377 | 1.170 |
Why?
|
| Cognition | 9 | 2019 | 458 | 1.170 |
Why?
|
| Silicon | 3 | 2021 | 17 | 1.050 |
Why?
|
| Avoidance Learning | 2 | 2025 | 68 | 1.040 |
Why?
|
| Self Concept | 5 | 2010 | 170 | 0.920 |
Why?
|
| Self Disclosure | 2 | 2018 | 43 | 0.900 |
Why?
|
| Radiation Monitoring | 4 | 2024 | 9 | 0.900 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2024 | 303 | 0.870 |
Why?
|
| Body Image | 5 | 2018 | 87 | 0.830 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 88 | 0.820 |
Why?
|
| Students | 5 | 2020 | 617 | 0.770 |
Why?
|
| Eating | 3 | 2012 | 164 | 0.690 |
Why?
|
| Stress, Psychological | 4 | 2010 | 641 | 0.640 |
Why?
|
| Psychotherapy | 3 | 2022 | 56 | 0.620 |
Why?
|
| Boron Neutron Capture Therapy | 3 | 2025 | 3 | 0.580 |
Why?
|
| Cognition Disorders | 2 | 2010 | 243 | 0.550 |
Why?
|
| Depression | 2 | 2024 | 837 | 0.540 |
Why?
|
| Thinking | 4 | 2010 | 36 | 0.530 |
Why?
|
| Neurons | 1 | 2024 | 1246 | 0.510 |
Why?
|
| Attitude to Health | 3 | 2011 | 336 | 0.490 |
Why?
|
| Anxiety | 3 | 2020 | 847 | 0.490 |
Why?
|
| Humans | 42 | 2025 | 42163 | 0.490 |
Why?
|
| Adolescent | 17 | 2019 | 5950 | 0.480 |
Why?
|
| Quality of Life | 3 | 2011 | 599 | 0.470 |
Why?
|
| Behavior Therapy | 3 | 2008 | 179 | 0.470 |
Why?
|
| Monte Carlo Method | 4 | 2024 | 66 | 0.450 |
Why?
|
| Adult | 20 | 2025 | 13458 | 0.450 |
Why?
|
| Glass | 3 | 2025 | 19 | 0.430 |
Why?
|
| Lithium | 3 | 2025 | 30 | 0.420 |
Why?
|
| Female | 29 | 2025 | 24018 | 0.420 |
Why?
|
| Young Adult | 13 | 2025 | 4936 | 0.410 |
Why?
|
| Scintillation Counting | 2 | 2025 | 4 | 0.410 |
Why?
|
| Radiation Dosage | 2 | 2024 | 37 | 0.400 |
Why?
|
| Psychology, Social | 1 | 2012 | 5 | 0.390 |
Why?
|
| Radiometry | 4 | 2024 | 8 | 0.390 |
Why?
|
| Phobic Disorders | 4 | 2013 | 25 | 0.380 |
Why?
|
| Pediatrics | 1 | 2012 | 69 | 0.370 |
Why?
|
| Mental Health | 3 | 2010 | 363 | 0.360 |
Why?
|
| Male | 22 | 2025 | 22779 | 0.350 |
Why?
|
| Optical Fibers | 2 | 2025 | 8 | 0.330 |
Why?
|
| Feeding Behavior | 2 | 2012 | 461 | 0.330 |
Why?
|
| Parents | 3 | 2014 | 359 | 0.320 |
Why?
|
| Cross-Sectional Studies | 8 | 2020 | 3077 | 0.320 |
Why?
|
| Resilience, Psychological | 1 | 2011 | 89 | 0.310 |
Why?
|
| Computer Simulation | 2 | 2024 | 404 | 0.310 |
Why?
|
| Equipment Design | 4 | 2024 | 143 | 0.300 |
Why?
|
| Affective Symptoms | 1 | 2009 | 60 | 0.300 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 185 | 0.290 |
Why?
|
| Culture | 1 | 2009 | 172 | 0.290 |
Why?
|
| Attitude | 1 | 2009 | 108 | 0.280 |
Why?
|
| Universities | 4 | 2020 | 539 | 0.270 |
Why?
|
| Middle Aged | 13 | 2021 | 11819 | 0.270 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 158 | 0.250 |
Why?
|
| Yoga | 2 | 2018 | 33 | 0.250 |
Why?
|
| Peer Group | 2 | 2012 | 173 | 0.250 |
Why?
|
| Prejudice | 1 | 2007 | 116 | 0.250 |
Why?
|
| Phantoms, Imaging | 2 | 2025 | 27 | 0.250 |
Why?
|
| Volition | 1 | 2006 | 9 | 0.250 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2006 | 25 | 0.240 |
Why?
|
| X-Ray Microtomography | 1 | 2025 | 22 | 0.240 |
Why?
|
| Self-Injurious Behavior | 1 | 2005 | 25 | 0.240 |
Why?
|
| Cerium | 1 | 2025 | 18 | 0.240 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2025 | 89 | 0.220 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2012 | 280 | 0.220 |
Why?
|
| Quality Assurance, Health Care | 1 | 2025 | 56 | 0.220 |
Why?
|
| Skin | 1 | 2005 | 185 | 0.220 |
Why?
|
| Patient Compliance | 1 | 2006 | 225 | 0.220 |
Why?
|
| Chick Embryo | 1 | 2024 | 77 | 0.220 |
Why?
|
| Health Education | 1 | 2007 | 358 | 0.210 |
Why?
|
| Mental Recall | 1 | 2004 | 81 | 0.210 |
Why?
|
| Axons | 1 | 2024 | 116 | 0.200 |
Why?
|
| Adaptation, Psychological | 3 | 2011 | 410 | 0.200 |
Why?
|
| Gene Regulatory Networks | 1 | 2024 | 143 | 0.200 |
Why?
|
| Gamma Rays | 4 | 2021 | 27 | 0.190 |
Why?
|
| Treatment Outcome | 7 | 2016 | 1586 | 0.190 |
Why?
|
| Professional-Patient Relations | 1 | 2022 | 60 | 0.190 |
Why?
|
| Focus Groups | 1 | 2024 | 398 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2024 | 382 | 0.180 |
Why?
|
| Sutures | 1 | 2021 | 2 | 0.180 |
Why?
|
| Suture Techniques | 1 | 2021 | 10 | 0.170 |
Why?
|
| Orthopedics | 1 | 2021 | 7 | 0.170 |
Why?
|
| Tensile Strength | 1 | 2021 | 27 | 0.170 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 30 | 0.170 |
Why?
|
| Obesity | 1 | 2009 | 1131 | 0.170 |
Why?
|
| Isotopes | 1 | 2020 | 9 | 0.170 |
Why?
|
| Fear | 3 | 2019 | 271 | 0.160 |
Why?
|
| Awareness | 2 | 2012 | 73 | 0.150 |
Why?
|
| Speech | 1 | 2019 | 16 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2024 | 722 | 0.150 |
Why?
|
| Students, Medical | 1 | 2021 | 153 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2002 | 297 | 0.140 |
Why?
|
| Viral Core Proteins | 1 | 2018 | 13 | 0.140 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2018 | 14 | 0.140 |
Why?
|
| Histone Acetyltransferases | 1 | 2018 | 20 | 0.140 |
Why?
|
| Oogenesis | 1 | 2018 | 29 | 0.140 |
Why?
|
| Arthralgia | 1 | 2018 | 12 | 0.140 |
Why?
|
| Ovarian Follicle | 1 | 2018 | 40 | 0.140 |
Why?
|
| Influenza A virus | 1 | 2018 | 31 | 0.140 |
Why?
|
| Embryonic Development | 1 | 2018 | 83 | 0.140 |
Why?
|
| Hawaii | 1 | 2024 | 2004 | 0.130 |
Why?
|
| Emotions | 2 | 2010 | 251 | 0.130 |
Why?
|
| Models, Psychological | 2 | 2009 | 141 | 0.130 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 22 | 0.130 |
Why?
|
| RNA Interference | 2 | 2018 | 246 | 0.130 |
Why?
|
| Phytotherapy | 1 | 2017 | 78 | 0.130 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 130 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2017 | 90 | 0.120 |
Why?
|
| Meditation | 2 | 2016 | 25 | 0.120 |
Why?
|
| Radiotherapy Dosage | 3 | 2025 | 8 | 0.120 |
Why?
|
| Chronic Disease | 2 | 2011 | 541 | 0.120 |
Why?
|
| Mice | 2 | 2024 | 6490 | 0.110 |
Why?
|
| Attention | 2 | 2010 | 165 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2017 | 189 | 0.110 |
Why?
|
| Anxiety Disorders | 2 | 2016 | 319 | 0.110 |
Why?
|
| Psychometrics | 2 | 2007 | 350 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2017 | 303 | 0.100 |
Why?
|
| Psychological Tests | 2 | 2012 | 56 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2013 | 123 | 0.100 |
Why?
|
| Genetic Vectors | 1 | 2013 | 165 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 188 | 0.100 |
Why?
|
| Parent-Child Relations | 1 | 2014 | 125 | 0.100 |
Why?
|
| Implosive Therapy | 1 | 2012 | 14 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 2012 | 74 | 0.090 |
Why?
|
| Animals | 4 | 2024 | 16695 | 0.090 |
Why?
|
| Zebrafish | 1 | 2013 | 146 | 0.090 |
Why?
|
| Methadone | 1 | 2012 | 24 | 0.090 |
Why?
|
| Narcotics | 1 | 2012 | 30 | 0.090 |
Why?
|
| Miniaturization | 1 | 2011 | 5 | 0.090 |
Why?
|
| Plastics | 1 | 2011 | 13 | 0.090 |
Why?
|
| Family | 1 | 2012 | 192 | 0.090 |
Why?
|
| Research Design | 1 | 2013 | 370 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 436 | 0.090 |
Why?
|
| Photons | 1 | 2010 | 29 | 0.090 |
Why?
|
| Reference Values | 1 | 2011 | 207 | 0.080 |
Why?
|
| Schools | 1 | 2012 | 283 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2011 | 89 | 0.080 |
Why?
|
| Radiation Protection | 2 | 2024 | 5 | 0.080 |
Why?
|
| Verbal Behavior | 1 | 2008 | 11 | 0.080 |
Why?
|
| Body Mass Index | 2 | 2013 | 916 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2012 | 188 | 0.070 |
Why?
|
| Education | 1 | 2009 | 60 | 0.070 |
Why?
|
| Pain | 1 | 2011 | 283 | 0.070 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 216 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 574 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 501 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 825 | 0.060 |
Why?
|
| Quality Control | 1 | 2025 | 41 | 0.060 |
Why?
|
| Persuasive Communication | 1 | 2004 | 9 | 0.050 |
Why?
|
| Japan | 1 | 2024 | 348 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 1051 | 0.050 |
Why?
|
| Task Performance and Analysis | 1 | 2002 | 47 | 0.050 |
Why?
|
| Americium | 1 | 2020 | 1 | 0.040 |
Why?
|
| Californium | 1 | 2020 | 2 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 1058 | 0.040 |
Why?
|
| Conditioning, Operant | 1 | 2019 | 90 | 0.040 |
Why?
|
| Reward | 1 | 2019 | 106 | 0.040 |
Why?
|
| Motivation | 1 | 2022 | 492 | 0.040 |
Why?
|
| Nucleocapsid Proteins | 1 | 2018 | 12 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2018 | 81 | 0.030 |
Why?
|
| Acetylation | 1 | 2018 | 108 | 0.030 |
Why?
|
| Oocytes | 1 | 2018 | 147 | 0.030 |
Why?
|
| Lysine | 1 | 2018 | 120 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2002 | 1516 | 0.030 |
Why?
|
| Myanmar | 1 | 2017 | 2 | 0.030 |
Why?
|
| Plant Stems | 1 | 2017 | 12 | 0.030 |
Why?
|
| Medicine, Traditional | 1 | 2017 | 23 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 663 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 173 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 184 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2018 | 317 | 0.030 |
Why?
|
| Dogs | 1 | 2017 | 201 | 0.030 |
Why?
|
| Aged | 3 | 2013 | 7982 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 230 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2018 | 884 | 0.030 |
Why?
|
| Virus Replication | 1 | 2018 | 318 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 1188 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 274 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 1010 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 599 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2018 | 426 | 0.030 |
Why?
|
| Child | 2 | 2013 | 3381 | 0.030 |
Why?
|
| Uridine | 1 | 2013 | 7 | 0.030 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2013 | 28 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 2013 | 149 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1265 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2013 | 59 | 0.030 |
Why?
|
| Boron | 1 | 2013 | 10 | 0.030 |
Why?
|
| Calibration | 1 | 2013 | 62 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 1416 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 318 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 1804 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 207 | 0.020 |
Why?
|
| Psychotherapy, Group | 1 | 2012 | 23 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 45 | 0.020 |
Why?
|
| Substance Abuse Detection | 1 | 2012 | 31 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 649 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2012 | 31 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 116 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 997 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 401 | 0.020 |
Why?
|
| United States | 1 | 2022 | 5072 | 0.020 |
Why?
|
| Iodides | 1 | 2011 | 5 | 0.020 |
Why?
|
| Cesium | 1 | 2011 | 8 | 0.020 |
Why?
|
| Luminescence | 1 | 2010 | 23 | 0.020 |
Why?
|
| Counseling | 1 | 2012 | 134 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2010 | 17 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 136 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2012 | 126 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1559 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 238 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 733 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 708 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2012 | 456 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 1848 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 1221 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2012 | 471 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 358 | 0.010 |
Why?
|